Myrtle S Potter sold $131k of GH
director at Guardant Health, Inc.. 2,626 shares at an average of $49.70, traded Jun 16, 2025, filed Jun 16, 2025.
Score components
- +15RoleDirector
- +11Trade size$131k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001576280-25-000181, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 12, 2025 | MOption exercise Common Stock10b5-1 | +6,674 | $0.00 | $0 | 20,737 | Jun 16, 2025 |
| Jun 15, 2025 | MOption exercise Common Stock10b5-1 | +69 | $0.00 | $0 | 20,806 | Jun 16, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stock10b5-1 | -2,626 | $49.70 | $131k | 18,180 | Jun 16, 2025 |
| Jun 12, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -6,674 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 15, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -69 | $0.00 | $0 | 274 | Jun 16, 2025 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 59Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $567k 5,451 shares | -44% | |
| 75Notable | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $2.4M 22,935 shares | -106% | |
| 67Notable | Guardant Health, Inc. | Michael Brian Bell Chief Financial Officer | $8.3M 80,362 shares | -74% | |
| 60Notable | Guardant Health, Inc. | Ian T Clark director | $3.1M 28,611 shares | -74% | |
| 0Weak | Guardant Health, Inc. | Myrtle S Potter director | $1,446 26 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.